← Back to headlines
Revolution Medicines' Experimental Cancer Drug Shows Significant Survival Boost
Revolution Medicines' experimental cancer pill has demonstrated a significant boost in overall survival in a late-stage study, with one report indicating it nearly doubled survival rates.
13 Apr, 12:04 — 13 Apr, 14:09
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (42/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center2
Center (2)
Reutersbloomberg
Right
Far R
Geographic diversity— 2 regions9/34
US2Intl1
Sources
Showing 3 of 3 sources
ReutersVery High7d ago
Revolution Medicines' experimental cancer pill boosts survival in late-stage study - Reuters
Revolution Medicines' experimental cancer pill boosts survival in late-stage study Reuters
Read full article →bloombergHigh7d ago
RevMed’s Cancer Drug Nearly Doubles Overall Survival in Pivotal Study - Bloomberg.com
RevMed’s Cancer Drug Nearly Doubles Overall Survival in Pivotal Study Bloomberg.com
Read full article →cnbcMostly Factual7d ago
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
Read full article →Coverage Timeline
First report: cnbc · 13 Apr, 12:04|Full coverage: 3 · 2h|Window: 2h
Left-leaningCenterRight-leaning
